Bajaj Healthcare · NSE: BAJAJHCARE · BSE: 539872
Q4 FY22 results · Jan–Mar 2022
Bajaj Healthcare reported revenue from operations of ₹175.71 crore (up 32.9% from Q4 FY21) and net profit of ₹17.47 crore (down 17.9% from Q4 FY21) for Q4 FY22 (Jan–Mar 2022), on a standalone basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 175.71 | 132.18 | +32.9% | 167.57 | +4.9% |
| Other income | 0.45 | 2.15 | −79.2% | 0.20 | +126.2% |
| Total income | 176.16 | 134.33 | +31.1% | 167.77 | +5.0% |
| Profit before tax | 16.93 | 30.19 | −43.9% | 23.33 | −27.4% |
| Net profit for the period | 17.47 | 21.28 | −17.9% | 17.45 | +0.2% |
| EPS, basic (₹) | 6.33 | 15.42 | not comparable | 6.32 | +0.2% |
| Net margin (%) | 9.9 | 16.1 | 10.4 |
Standalone
- Filed with BSE
- 21 May 2022, 16:56 IST
- Board meeting
- 17 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE